Respiratory somnology: a clinical update
Verleden G. M., Buyse B., Pevernagie D., Demedts M.
Eur Respir Rev 2007; 16: 113-114 |   |
Ventilatory support and pharmacological treatment of patients with central apnoea or hypoventilation during sleep
Pevernagie D., Janssens J. P., De Backer W., Elliott M., Pepperell J., Andreas S.
Eur Respir Rev 2007; 16: 115-124 |  |
Treatment of obstructive sleep-disordered breathing with positive airway pressure systems
Pevernagie D., Masa J. F., Meurice J. C., Farre R., Marrone O., Rodenstein D.
Eur Respir Rev 2007; 16: 125-131 | |
Alternatives for OSAHS treatment: selection of patients for upper airway surgery and oral appliances
Boudewyns A., Marklund M., Hochban W.
Eur Respir Rev 2007; 16: 132-145 | |
Treatment effects of sleep apnoea: where are we now?
Buyse B., the participants of working group 2
Eur Respir Rev 2007; 16: 146-168 | |
Sleep apnoea, hypertension and vascular disease: where are we now?
Buyse B., Hedner J., the participants of working group 2
Eur Respir Rev 2007; 16: 169-182 | |
Treatment of obstructive and central sleep apnoea in heart failure: practical options
Javaheri S.
Eur Respir Rev 2007; 16: 183-188 | |
Sleep apnoea and driving: how can this be dealt with?
Krieger J.
Eur Respir Rev 2007; 16: 189-195 | |
Metabolic disturbances in patients with obstructive sleep apnoea syndrome
Harsch I. A.
Eur Respir Rev 2007; 16: 196-202 | |
Mortality in sleep apnoea syndrome: a review of the evidence
Lavie P.
Eur Respir Rev 2007; 16: 203-210 | |
"WHICH PATIENTS SHOULD BE TREATED WITH ANTI-IGE?". K-M. BEEH. EUR RESPIR REV 2007; 16: 104, 85 87.
Eur Respir Rev 2007; 16: 211 | |